James A. Rechtin insider trades: Humana (HUM) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 14, 2025 | HUM | ↑ Buy | 6,530 | $229.25 | $1.5M | Indirect | May 16, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HUM insiders
Open-market trades in the last 12 months
About James A. Rechtin's insider trades
James A. Rechtin is President & CEO at Humana (HUM). Since May 14, 2025, James has reported 1 open-market purchase worth $1.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), shares withheld for taxes (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HUM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.